Gender impact in systemic lupus erythematosus

Clinical and Experimental Rheumatology

Volumn 22, Issue 6, 2004, Pages 713-721

  Soto, M E ^b   Vallejo, M ^b   Guillen F ^b   Simon J A ^a   Arena, E ^b   Reyes, Pedro A ^b  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Ethnicity; Gender difference; Male disease; Survival rate and systematic literature review; Systemic Lupus Erythematosus (SLE)

Indexed keywords

AUTOANTIBODY; CARDIOLIPIN ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY;

ADULT; AGED; AUTOIMMUNE DISEASE; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISCOID LUPUS ERYTHEMATOSUS; DISEASE ACTIVITY; DISEASE CLASSIFICATION; FEMALE; FREQUENCY ANALYSIS; HUMAN; HYPOCOMPLEMENTEMIA; IMMUNOASSAY; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; MEXICO; MORTALITY; PERICARDITIS; PRIORITY JOURNAL; PROBABILITY; PSYCHOSIS; RATING SCALE; REVIEW; SCHOOL CHILD; SEX DIFFERENCE; SOCIOECONOMICS; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC REVIEW; SYSTEMIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; VALIDATION PROCESS; VENEREAL DISEASE REACTION TEST;

FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEXICO; SEX DISTRIBUTION; SURVIVAL RATE;

EID: 11044226338     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. CHRISTIAN CL, ELKON KB: Autoantibodies to intracellular proteins. Clinical and biological implications. Am J Med 1986; 80: 53-61.
2. COCHRANE CG, KOFFLER D: Immune complex disease in experimental animals and man. Adv Immunol 1973; 16: 186-264.
3. WALLACE DJ, PODELL T, WEINER J, JAMES RK, FOROUZESH S, DUBOIS EL: Systemic lupus erythematosus - Survival patterns. Experience with 609 patients. JAMA 1981; 245: 934-8.
4. MILLER MH, UROWITZ MB, GLADMAN DD, KILLINGER DW: Systemic lupus erythematousus in males. Medicine 1983; 62: 327-34.
5. ARCE-SALINAS A, CARDIEL MH, GUZMAN J, ALCOCER-VARELA J: Validity of retrospective disease activity assessment in systemic lupus erythematosus. J Rheumatol 1996; 23: 846-9.
6. PANUSH RC, EDWARDS NL, LONGLEY S, WEBSTER E: Rhupus syndrome. Arch Int Med 1988; 148.,1633-6.
7. AUSTIN HA, MUENZ LR, JOYCE KM et al.: Prognostic factors in lupus nephritis. Am J Med 1983; 75: 382-91.
8. LARSON DL: Systemic Lupus Erythematosus. Boston, Little, Brown, 1961.
9. BALLOU SP, KHAN MA, KUSHNER I: Clinical features of systemic lupus erythematosus. Differences related to race and age of onset. Arthritis Rheum 1982; 25: 55-60.
10. KAUFMAN LD, GOMEZ-REINO JJ, HEINICKE MH, GOREVIC PD: Male lupus: retrospective analysis of the clinical and laboratory features of 52 patients, with a review of the literature. Semin Arthritis Rheum 1989; 18: 189-97.
11. WARD MM, STUDENSKI S: Systemic lupus erythematosus in men: a multivariate analysis of gender differences in clinical manifestations. J Rheumatol 1990; 17: 220-4.
12. KOH WH, FONG KY, BOEY ML, FENG PH: Systemic lupus erythematosus in 61 oriental males. A study of clinical and laboratory manifestations. B J Rheumatol 1994; 33: 339-42.
13. AZIZAH MR, AINOL SS, KONG NCT, NORMAZNAH Y, RAHIM MN: Gender differences in the clinical and serological features of systemic lupus erythematosus in malaysian patients. Med J Malaysia 2001; 56: 302-7.
14. MOK CC, LAU CS, CHAN TM, WONG RWS: Clinical characteristics and outcome of southern Chinese males with systemic lupus erythematosus. Lupus 1999; 8: 188-96.
15. MOLINA JF, DRENKARD C, MOLINA J et al.: Systemic lupus erythematosus in males a study of 107 Latin-American patients. Medicine 1996; 75: 124-30.
16. ARANOW C, DEL GUIDICE J, BARLAND P, WEINSTEIN A: Systemic lupus erythematosus disease severity in men and women: a case-control study. J Rheumatol 2002; 29: 1674-7.
17. STHOEGER ZM, GELTNER D, RIDER A, BENTWICH Z: Systemic lupus erythematosus in 49 Israeli males: Retrospective study. Clin Exp Rheumatol 1987; 5:233-240.
18. WANG F, WANG CL, TAN CT, MANIVASAGAR M: Systemic lupus erythematosus in Malaysia: a study of 539 patients and comparison of prevalence and disease expression in different racial and gender groups. Lupus 1997; 6: 248-53.
19. HOCHBERG MC, BOYD RE, AHEARN JM et al.: Systemic lupus erythematosus: a review of clinic-Laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine 1985; 64: 285-95.
20. PANDE I, MALAVIYA AN, SEKHARAN NG, KAILASH S, UPPAL SS, KUMAR A: SLE in Indian men: Analysis of the clinical and laboratory features with a review of the literature. Lupus 1994; 3: 181-6.
21. CEVERA R, KHAMASHTA MA, FONT J et al. and the European Working Party on Systemic Lupus Erythematosus: Systemic lupus erythematosus: Clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. Medicine 1993; 72: 113-24.
22. INMAN RD, JOVANOVIC L, MARKENSON JA, LONGCOPE CH, DAWOOD MY, LOCKSHIN MD: Systemic lupus erythematosus in men. Genetic and endocrine features. Arch Intern Med 1982; 142: 1813-5.
23. ALGER M, ALARCÓN SEGOVIA D, RIVERO SJ: Hemolytic anemia and thorombocytopenic purpura: Two related subsets of lupus erythematosus. J Rheumatol 1977; 4: 351-7.
24. TAREYEVA A, JANUSHKEVITCH TN, TUGANBEKOVA SK: Lupus nephiritis in males and females. Proc EDTA 1984; 21: 712-6.
25. ROTHFIELD NF, FRANGIONE B, FRANKLIN EC: Slowly sedimenting, mercaptoethanol-resistant antinuclear factors related antigenically to M immunoglobulins (m-globulins) in patients with systemic lupus erythematosus. J Clin Invest 1965; 44: 62-72.
26. LAHITA RG, BRADLOW HL, KUNKEL HG, FISHMAN J: Alterations of estrogen metabolism in systemic lupus erythematosus. Arthritis Rheum 1979; 22: 195-8.
27. LAHITA RG, BRADLOW HL, KUNKEL HG et al.: Increased 16-hydroxylation of estradiol in systemic lupus erythematosus. J Clin Endocrinol Metab 1981; 53: 174-8.
28. LAHITA RG, KUNKEL HG, BRADLOW HL: Increased oxidation of testosterone in systemic lupus erythematosus. Arthritis Rheum 1983; 26: 1517-21.
29. LAVALLE C, LOYO E, PANIAGUA R et al.: Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus. J Rheumatol 1987; 14: 268-72.
30. STAHL-HALLENGREN CH, JONSEN A, NIVED O, STURFELT G: Incidence studies of systemic lupus erythematosus in southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis. J Rheumatol 2000; 27: 685-91
31. CHANG DM, CHANG CC, KUO SY, CHU SJ, CHANG ML: Hormonal profiles and immunological studies of male lupus in Taiwan. Clin Rheumatol 1999; 18: 158-162.
32. BUCKMAN KJ, MOORE SK, EBBIN AJ, COX MB, DUBOIS EL: Familial systemic lupus erythematosus. Arch Intern Med 1978; 138: 1674-1676.
33. CLELAND LG, BELL DA, WILLIAMS M, SAURINO BC: Familial lupus. Family studies of HLA and serologic findings. Arthritis Rheum 1978; 21: 183-191.1813-15.
34. FORMIGA F, NOLLA JM, MITJAVILA F, BONNIN, NAVARRO MA, MOGA I: Bone mineral density and hormonal status in men with systemic lupus erythematosus. Lupus 1996; 5: 623-6.
35. ROSS GL, BARLAND P, GRAYZEL AI: The immunoglobulin class of anti-DNA antibodies: Detection by a fluorometric immunoassay: clinical and pathological correlation in SLE. J Rheumatol 1978: 373-83.
36. ROSNER S, GINZLER EM, DIAMOND HS et al.: A multicenter study of outcome in systemic lupus erythematosus. Arthritis Rheum 1982; 25: 612-7.
37. LEE TH: The practice guidelines in cardiovascular medicine. In BRAUNWALLD E (Ed.): Heart Disease, vol. 11, 5th ed., Philadelphia, Saunders Co., 1997, pg. 1939
38. MAGIL AB, BALLON HS, RAE A: Focal proliferative lupus nephritis. A Clinicopathologic Study Using the W.H.O. Classification. Am J Med 1982; 72: 620-30.